These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10736074)

  • 1. Onset and duration of action of rocuronium in children receiving chronic anticonvulsant therapy.
    Soriano SG; Kaus SJ; Sullivan LJ; Martyn JA
    Paediatr Anaesth; 2000; 10(2):133-6. PubMed ID: 10736074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of time course of neuromuscular blockade in young children following rocuronium and atracurium.
    Ribeiro FC; Scheiber G; Marichal A
    Eur J Anaesthesiol; 1998 May; 15(3):310-3. PubMed ID: 9649990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of anticonvulsant therapy on two doses of rocuronium-induced neuromuscular blockade.
    Koenig HM; Hoffman WE
    J Neurosurg Anesthesiol; 1999 Apr; 11(2):86-9. PubMed ID: 10213434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onset and recovery of neuromuscular blockade after two doses of rocuronium in children.
    Ross AK; Dear GL; Dear RB; Margolis JO; Ginsberg B
    J Clin Anesth; 1998 Dec; 10(8):631-5. PubMed ID: 9873962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of vecuronium in children receiving phenytoin or carbamazepine for chronic anticonvulsant therapy.
    Soriano SG; Sullivan LJ; Venkatakrishnan K; Greenblatt DJ; Martyn JA
    Br J Anaesth; 2001 Feb; 86(2):223-9. PubMed ID: 11573664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between rate of administration of an intubating dose of rocuronium and time to 50% and 90% block at the adductor pollicis muscle.
    De Haes A; Eleveld DJ; Wierda JM
    J Clin Monit Comput; 2000; 16(3):219-22. PubMed ID: 12578106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rocuronium-induced neuromuscular blockade is affected by chronic phenytoin therapy.
    Hernández-Palazón J; Tortosa JA; Martínez-Lage JF; Pérez-Ayala M
    J Neurosurg Anesthesiol; 2001 Apr; 13(2):79-82. PubMed ID: 11294462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromuscular recovery following rocuronium bromide single dose in infants.
    Rapp HJ; Altenmueller CA; Waschke C
    Paediatr Anaesth; 2004 Apr; 14(4):329-35. PubMed ID: 15078379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between mivacurium, rocuronium, and vecuronium during general anesthesia.
    Kim DW; Joshi GP; White PF; Johnson ER
    Anesth Analg; 1996 Oct; 83(4):818-22. PubMed ID: 8831328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intubating conditions and blockade after mivacurium, rocuronium and their combination in young and elderly adults.
    Motamed C; Donati F
    Can J Anaesth; 2000 Mar; 47(3):225-31. PubMed ID: 10730732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromuscular effects of rocuronium in patients receiving beta-adrenoreceptor blocking, calcium entry blocking and anticonvulsant drugs.
    Loan PB; Connolly FM; Mirakhur RK; Kumar N; Farling P
    Br J Anaesth; 1997 Jan; 78(1):90-1. PubMed ID: 9059213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rocuronium-induced neuromuscular block is affected by chronic carbamazepine therapy.
    Spacek A; Neiger FX; Krenn CG; Hoerauf K; Kress HG
    Anesthesiology; 1999 Jan; 90(1):109-12. PubMed ID: 9915319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intubating conditions and neuromuscular block after divided dose mivacurium or single dose rocuronium.
    Patel N; Kamath N; Smith CE; Pinchak AC; Hagen JH
    Can J Anaesth; 1997 Jan; 44(1):49-53. PubMed ID: 8988824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of stabilization of control responses affects the onset and duration of action of rocuronium but not suxamethonium.
    Symington MJ; McCoy EP; Mirakhur RK; Kumar N
    Eur J Anaesthesiol; 1996 Jul; 13(4):377-80. PubMed ID: 8842660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of rocuronium and mivacurium to succinylcholine during outpatient laparoscopic surgery.
    Tang J; Joshi GP; White PF
    Anesth Analg; 1996 May; 82(5):994-8. PubMed ID: 8610912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated recovery from pipecuronium in patients treated with chronic anticonvulsant therapy.
    Jellish WS; Modica PA; Tempelhoff R
    J Clin Anesth; 1993; 5(2):105-8. PubMed ID: 8386533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended duration of action of rocuronium in postpartum patients.
    Pühringer FK; Sparr HJ; Mitterschiffthaler G; Agoston S; Benzer A
    Anesth Analg; 1997 Feb; 84(2):352-4. PubMed ID: 9024027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rocuronium 0.3 mg x kg-1 (ED95) induces a normal peak effect but an altered time course of neuromuscular block in patients with Duchenne's muscular dystrophy.
    Muenster T; Schmidt J; Wick S; Forst J; Schmitt HJ
    Paediatr Anaesth; 2006 Aug; 16(8):840-5. PubMed ID: 16884467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response relationships for neostigmine antagonism of rocuronium-induced neuromuscular block in children and adults.
    Abdulatif M; Mowafi H; al-Ghamdi A; el-Sanabary M
    Br J Anaesth; 1996 Dec; 77(6):710-5. PubMed ID: 9014620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-response relationships for edrophonium and neostigmine antagonism of rocuronium bromide (ORG 9426)-induced neuromuscular blockade.
    Naguib M; Abdulatif M; al-Ghamdi A
    Anesthesiology; 1993 Oct; 79(4):739-45. PubMed ID: 8214753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.